The Children’s Tumor Foundation contributes in-kind to the IMI-funded public-private NF partnerships in coalition with European Federation of Pharmaceutical Industries and Associations (EFPIA) partners. CTF Europe is focused on leveraging investments across the European landscape – whether in NF or in related fields in rare disease or cancer – that may benefit NF research, and hence NF patients. This means connecting a united community of academic professionals, corporate partners, regulatory agencies, government agencies, and most important of all, patients and their caregivers. All these stakeholders collaborate to build transnational EU-wide and worldwide connections to catalyse new discoveries, and guarantee the efficient translation of all the discoveries into clinical benefit. To read more about CTF’s role in IMI-funded initiatives that will shape the future of drug development, click here.
CTF is an Associated Research Partner of the Innovative Medicine Initiative (IMI)
